Pharmaceuticals

Increasing Cancer Incidence Accelerates Demand For Targeted Immunotherapies Is Supporting Development Across The Personalized Cancer Vaccines Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Personalized Cancer Vaccines Market Change Between 2026 And 2030?

The personalized cancer vaccines market size has observed significant expansion over recent years. Its projected growth will take it from $256.65 billion in 2025 to $273.05 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.4%. This historical market expansion can be attributed to several factors, including advances in cancer genomics, the persistent unmet need in oncology treatments, the inherent limitations of traditional cancer therapies, the increasing volume of immunotherapy research, and enhanced funding allocated to cancer research.

The personalized cancer vaccines market is projected for substantial expansion in the coming years, with its size expected to reach $350.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This anticipated growth throughout the forecast period is driven by factors such as the increasing adoption of personalized medicine, rising cancer incidence rates, advancements in neoantigen discovery, growing collaboration among biotech firms, and supportive regulatory frameworks. Major trends expected during this period include a heightened focus on personalized immunotherapy, a rise in the use of genomic tumor profiling, the expansion of therapeutic cancer vaccines, increasing integration with precision oncology, and more extensive clinical trial activity in cancer vaccines.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19136&type=smp

What Key Growth Drivers Are Influencing The Personalized Cancer Vaccines Market?

The rising incidence of cancer is anticipated to fuel the expansion of the personalized cancer vaccine market in the future. Cancer encompasses a category of illnesses marked by unregulated cell proliferation, capable of infiltrating adjacent tissues and metastasizing throughout the body. The growing occurrence of cancer is fueled by factors such as demographic shifts towards older populations, evolving lifestyles, exposure to environmental hazards, and advancements in diagnostic methods. The personalized cancer vaccine market contributes to oncology care by providing vaccines customized to an individual patient’s tumor antigens, thereby bolstering the immune system’s capacity to recognize and eradicate malignant cells. For example, data released in July 2024 by the Australian Institute of Health and Welfare (AIHW), an Australia-based government body, showed that cancer diagnoses in Australia climbed from 160,570 cases in 2022 to 164,694 cases in 2023, representing a notable year-on-year rise. Consequently, the growing frequency of cancer cases is stimulating the development of the personalized cancer vaccine market.

Which Segment Groups Define The Personalized Cancer Vaccines Market Landscape?

The personalized cancer vaccines market covered in this report is segmented –

1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma

3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action

4) By Route Of Administration: Injectables, Other Routes Of Administration

5) By End Use: Hospitals, Clinic, Other End Users

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines, Combination Vaccines

2) By Therapeutic Cancer Vaccines: Dendritic Cell Vaccines, Peptide-Based Vaccines, DNA Vaccines, RNA Vaccines, Whole Cell Vaccines

What Trends Are Affecting The Growth Of The Personalized Cancer Vaccines Market?

Leading firms within the personalized cancer vaccine market are concentrating on creating cutting-edge therapeutic approaches, specifically personalized immunotherapy tailored to address individual patient tumor mutations, with the aim of boosting treatment accuracy and achieving better clinical results. This personalized immunotherapy involves bespoke cancer therapies that leverage a patient’s unique genetic and tumor mutation information, frequently administered via dendritic cell-based vaccines or neoantigen-targeting systems, to elicit a specific immune reaction against cancerous cells. As an illustration, in August 2024, UCLA Health, a healthcare entity based in the US, initiated an unprecedented clinical trial to assess a personalized cancer vaccine. This vaccine targets the H3 G34 mutation found in diffuse hemispheric gliomas, employing dendritic cells to provoke an immune response against the RNA irregularities induced by this severe mutation, thereby presenting a hopeful treatment avenue for adolescents and young adults who commonly face restricted treatment alternatives and low survival prospects.

Which Companies Are Influencing The Personalized Cancer Vaccines Market?

Major companies operating in the personalized cancer vaccines market are Moderna Inc., CureVac AG, BioNTech SE, Genentech Inc., Merck & Co. Inc., GlaxoSmithKline plc, Achilles Therapeutics Plc, Evaxion Biotech AS, Geneos Therapeutics Inc., ISA Pharmaceuticals BV, VAXIMM GmbH, EpiVax Therapeutics Inc., Personalis Inc., Catalent Inc., Gritstone bio Inc., Neon Therapeutics Inc., Nouscom AG, Vaccitech plc, Agenus Inc., Transgene SA

Access The Complete Personalized Cancer Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/personalized-cancer-vaccines-global-market-report

Which Region Holds The Largest Share In The Personalized Cancer Vaccines Market?

North America was the largest region in the personalized cancer vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Personalized Cancer Vaccines Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=19136&type=smp

Browse Through More Reports Similar to the Global Personalized Cancer Vaccines Market 2026, By The Business Research Company

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Cervical Cancer Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/cervical-cancer-vaccine-global-market-report

Dendritic Cell Cancer Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/dendritic-cell-cancer-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795